Through a gene expression meta-analysis of publicly available data, we demonstrate that markers of senescence (i.e., GDF15, COMP, and CDKN2A) and senescence-related pathways (i.e., P53 and EMT) are significantly upregulated in SSc-ILD compared to controls. This evidence concerns the gene TP53 and systemic sclerosis.